
æ°åã³ãããŠã€ã«ã¹ã®ç ç©¶ææŒæŽ©èª¬ãé èœããããšããŠããããã®é¡æ«ãªã©
ããžã£ãžã£ãžããé ãããšããŠãç¡é§ã ã£ããã ããïŒãã¡ãŠãããããð¥Žã
ã£ãŠãªæãã®ã»ãªããåããããªãããç»åã§ããããŸãð
ãïŒããã®è²Žæ¹ïŒWTMãŸãšãèšäºã®ãã«äœ¿ããã³ãããšãèšããªãïŒã¡ãïŒðŠðŠ
#翻蚳èšäºã§ããããåºã ãã¯æ¢ãã
âŠããŠããŠãä»å翻蚳æãæ²èŒãããŠé ããŸãã®ã¯
The Defenderãšãããµã€ãã®èšäºã§ããããŸããŒãïŒðâšâš
ãã®ãµã€ãã¯æããããšãã§ããªãèšäºãæäžããŠæ¥ãã®ã§åé³¥çã«ã奜ããªãµã€ãã ã£ããããŸãw
éå»ã«ã¯ããã®èšäºã®ãœãŒã¹ãšããŠæ±ãããŠé ããŸããð
ä»åã®èšäºã§ã¯ãããããæ°åã³ãããŠã€ã«ã¹ã®ã©ããªãŒã¯âппŒ¢ã®ç ç©¶æããæŒæŽ©ãã¡ãŸã£ããšããã€ãéããæ¡ä»¶ãããã¡ãŠããçé ãšããè²ããªçµç¹ãé èœããããšããŠããçè·¡ã®ã现ããç®ãªèšè¿°ãªãããèšãããŠãããŸãð¥Žâšâš
åžžã
ã®äºã§ã¯ãããŸãããåºæ¬çã«ã¯ãã³ã¬ãçå®ã§ããŒãïŒããšèšãã€ããã§ã¯ãããŸããðŠ
ãã å
容çã«ããµã€ãã®ä¿¡é Œæ§ãšããŠãå®å
šã§ããããšèããŸããã®ã§ãä»ååãæ±ãããŠé ããŠãããŸãð
ä»åã®èšäºã§ã¯æ¥æ¬èªã§ã®èŠèªæ§ãéèŠããçº
COVID-19
SARS-CoV-2
ãšããèªå¥ãåæ¹ãšã"æ°åã³ãããŠã€ã«ã¹"ãšèš³ããŠããŸãã
å³å¯ã«ã¯èš³ããã«åããå¿
èŠãããã®ã§ãããä»åã®èšäºãéåžžã«é·ãé£è§£ãªçºãç°¡ç¥åã®çºã«ããããŠãããŸãð
ãšããäºã§ãããïŒã¿ããªã§èªãã§ã¿ãããïŒ
#幎代ãåããããã ãª
æ°åã³ãããŠã€ã«ã¹ïŒã©ããªãŒã¯(â»ç ç©¶æããã®æŒæŽ©èª¬)ã®é èœã¯åŽ©å£å¯žåã§ããïŒ
ç ç©¶å®€æŒæŽ©èª¬ãããã»ã©ãŸã§ã«è«è°ãããŠããæå€§ã®çç±ã¯ããããäºå®ãšèªãããšãè°äŒãç ç©¶ç£æ¥ãæå¶ããããåŸãªããªããããªã®ã§ãã
ByïŒãžã§ã»ãã»ã¡ã«ã³ã©å士

ã¹ããŒãªãŒã®æŠèŠ
2022幎1æãäžé¢ç£èŠå§å¡äŒã®å ±åå ã¯ãåœç«è¡çç ç©¶æ(NIH)ãšã®éã§ããåããããé»åã¡ãŒã«ãäžæ¬ããŠå ¬éããŸãããThe Interceptã®ãžããŒã»ããã¢ã¹ãèµ·ãããæ å ±å ¬éæ³(FOIA)蚎èšã§ããç·šéãããŠããªãNIHã®éä¿¡æãå ¬éãããããšã«ãªããŸããã
SARS-CoV-2(æ°åã³ãããŠã€ã«ã¹)ã¯ãäžåœã®æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æ(WIV)ããéãåºããéºäŒåæäœããããŠã€ã«ã¹ãšæãããNIHã®æå°è ã®éã§å€§ããªæžå¿µããã£ãããšãé»åã¡ãŒã«ã§æããã«ãããŸããã
ãã®ã¡ãŒã«ã«ã¯ã圌ãããã®ãŠã€ã«ã¹ã®äœæã«è³éãæäŸããå¯èœæ§ã«ç¥çµè³ªã«ãªã£ãŠããããã®èµ·æºã«é¢ããçåãæããããšæ±ºæããŠããããšã瀺ãããŠããŸãã
ãŠãšã«ã«ã ã»ãã©ã¹ãã®ãã£ã¬ã¯ã¿ãŒã§ãããžã§ã¬ããŒã»ãã¡ãŒã©ãŒå士ãæéããç§åŠè ã°ã«ãŒããçºè¡šããè«æã«ããã°ããŠã€ã«ã¹ã¯æå³çã«æäœãããçµæã§ãªãããšã¯æããã§ãããšã®äºã§ãã圌ãã¯ã"ç 究宀ã§ã®å¶çºçãªåµé ã¯åŠå®ã§ããªãããèªç¶é²åãæãå¯èœæ§ã®é«ãã·ããªãªã§ãã"ããšãèªããŠããŸãããããã®ç§åŠè ã®äžã«ã¯ã以åã«ãã¢ã³ãœããŒã»ãã¡ãŠããžã®é»åã¡ãŒã«ã§éºäŒåæäœã瀺åãã詳现ã話ããŠããè ãããŸããã
ãã¡ãŠããç·šéããäœã®æ ¹æ ããªãå®éšå®€æŒæŽ©èª¬ã"è«ç Ž"ãã"Proximal Origin(è¿äœèµ·æº)"è«æã¯ãå²äžæãèªãŸããåºçè«æãšãªããŸããã2,000以äžã®ã¡ãã£ã¢ãèªåãã¡ã®ãããã¬ã³ããæ¯æããããã«åŒçšããã®ã§ãã
2022幎1æãäžé¢ç£èŠå§å¡äŒã®å ±åå ã¯ãåœç«è¡çç ç©¶æãšã®éã§ããåããããé»åã¡ãŒã«ãäžæ¬ããŠå ¬éããŸããã
The Interceptã®ãžããŒã»ããã¢ã¹ãèµ·ãããæ å ±å ¬éæ³ã®èšŽèšã§ãã2022幎11æäžæ¬ããã¡ãŠããåœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æ(NIAID)æé·ã®è·ãéãæºåãããŠãããšãã«ãæªä¿®æ£ã®NIHéä¿¡ææžãå ¬éãããããŸããã
ã€ãŸããæ°åã³ãããŠã€ã«ã¹ã¯äžåœã®æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æããæµåºãããéºäŒåæäœããããŠã€ã«ã¹ã§ããããšãæããã«ãªã£ãã®ã§ãã
(1æ17æ¥ã®ãã€ãã¿ãŒã®ã¹ã¬ããã§ãååçç©åŠè
ã®ãªãã£ãŒãã»ãšãã©ã€ãå士ããç ç©¶æèµ·æºèª¬ãèŠçŽããŠããŸã)
ãã®æžç°¡ããNIHã®å¹¹éšã¯ã"A)èªåãã¡ããã®ãŠã€ã«ã¹ã®äœæã«è³éãæäŸããå¯èœæ§ã«ç¥çµè³ªã«ãªã£ãŠããããš"ããŸãã"B)ãã®èµ·æºã«ã€ããŠã®çåãå°ã蟌ããããšæ±ºæããŠããããš"ãæããã«ãªããŸããã
äž»ãªèª¿æ»çµæã®ãŸãšã
äžé¢ç£èŠå§å¡äŒã®å ±åã«ãããšïŒ
"æ¬æ¥å ¬éãããé»åã¡ãŒã«ã®æç²ã§ã以äžã®ããšãæããã«ãªããŸããïŒ
2020幎1æ27æ¥ïŒ[ã¢ã³ãœããŒ]ãã¡ãŠãå士ã¯ãNIAID[åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æ]ããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã«è³éæäŸããŠããããšãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æããšã³ãã«ã¹ã®äžè«ãå¥çŽè ã ã£ãããšããšã³ãã«ã¹ã婿éã®å ±åãç¹ã«NIAIDãæ°èŠã³ãŠã¢ãªã³ãããŠã£ã«ã¹ã«é¢ããæ©èœç²åŸã®å¯èœæ§ãç¥ã£ãŠãã婿éãéµå®ããŠããªãããšããç¥ã£ãŠããã®ã§ãã
2020幎2æ1æ¥ïŒãã¡ãŠãå士ã[åœæã®NIHé·å®]ãã©ã³ã·ã¹ã»ã³ãªã³ãºå士ãããã³å°ãªããšã11人ã®ä»ã®ç§åŠè ããæ°åã³ãããŠã€ã«ã¹ã«ã€ããŠè©±ãåãããã«é»è©±äŒè°ãæéããŸããããã®é»è©±äŒè°ã§ããã¡ãŠãå士ãšã³ãªã³ãºå士ã¯ãŸããæ°åã³ãããŠã€ã«ã¹ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æããæµåºããæå³çã«éºäŒåæäœãããå¯èœæ§ãããããšãèŠåãããŸããã
2020幎2æ4æ¥ïŒãã¡ãŠãå士ãšã³ãªã³ãºå士ãšè©±ããåŸãé»è©±äŒè°ã®åå è 4人ã¯ããŠã€ã«ã¹ãæŠæŒ¢ã®ç 究宀ã«ç±æ¥ãããšããèããæšãŠããThe Proximal Origin of SARS-CoV-2ããšé¡ããè«æãå·çããŸããã[Nature Medicineèª]ã«æçµçã«æ²èŒãããåã«ããã®è«æã¯ç·šéãšæ¿èªã®ããã«ãã¡ãŠãå士ã®ããšã«éãããŸããã
2020幎4æ16æ¥ïŒæåã®é»è©±äŒè°ãã2ã¶æä»¥äžçµã£ãŠãã³ãªã³ãºå士ã¯ãã¡ãŠãå士ã«ã¡ãŒã«ãéããNature Medicineã®è«æ-åºçåã«èŠãŠç·šéããæ©äŒãäžãããã-ãå®éšå®€æŒæŽ©ä»®èª¬ã朰ããŠããªãããšã«å€±æãããNIHãå®éšå®€æŒæŽ©ä»®èª¬ããé®ãããããã«ãã£ãšã§ããããšã¯ãªããããšè³ªåããŸããã
2020幎4æ17æ¥ïŒã³ãªã³ãºå士ããã£ãšäžéã«å§åããããããæç¢ºã«æ±ããåŸããã¡ãŠãåå£«ã¯æããæ°åã³ãããŠã€ã«ã¹ãæŠæŒ¢ã®ç ç©¶æããæŒãããšãã仮説ãããã«æŒããšã©ããããšããã¯ã€ãããŠã¹ã®æŒå£ããNature Medicineã®è«æãåŒçšããŸããã"
ãã¡ãŠããç ç©¶æã®æ å ±æŒæŽ©ã®å¯èœæ§ã瀺å
2020幎1æ31æ¥ããã¡ãŠãã¯ãŠã§ã«ã«ã ã»ãã©ã¹ãã®ãã£ã¬ã¯ã¿ãŒã§ãããžã§ã¬ããŒã»ãã¡ãŒã©ãŒå士ãããé²åçç©åŠè ã§ã«ãªãã©ã«ãã¢å·ã©ãã€ã®ã¹ã¯ãªãã¹ç ç©¶æã®å ç«åŠã»åŸ®çç©åŠéšéã®ææã§ããã¯ãªã¹ãã£ã¢ã³ã»ã¢ã³ããŒã»ã³å士ã«é»è©±ããããã«ãšã®é»åã¡ãŒã«ãåãåããŸããã
1æ19æ¥ã®The Interceptã®å ±éã«ãããšïŒ
"ãã®å€ããã¡ãŠãã¯ã¢ã³ããŒã»ã³ãšé»è©±ã§è©±ãããã®å 容ãèããŠæããã«äžå®ãèŠããŸãããé»è©±ã®åŸããã¡ãŒã©ãŒã«éã£ãé»åã¡ãŒã«ã«ã¯ã次ã®ããã«æžãããŠããŸããïŒ
"ç§ã¯[ã¢ã³ããŒã»ã³]ã«ãã§ããã ãæ©ã圌ãšãšãã£ãŒã»ããŒã ãºãé²åçç©åŠè ã®ã°ã«ãŒããçµæããåœŒã®æžå¿µã劥åœãã©ãããããŒã¿ãæ éã«æ€èšããããã«ãšèšããŸããããããŠãããå šå¡ããã®æžå¿µã«åæãããªãã°ãé©åãªåœå±ã«å ±åããã¹ãã ããšã
"ã¢ã¡ãªã«ãªãFBIãã€ã®ãªã¹ãªãMI5â²ãšãããšããã§ãããããã¢ã³ããŒã»ã³ã®æžå¿µã¯äœã ã£ãã®ãïŒãŸãããªãFBIã«éå ±ããã»ã©åå®ãªåé¡ã ã£ãã®ã§ããããïŒ
"ã¢ã³ããŒã»ã³ã¯åãæ¥ã®å€ããã¡ãŠããžã®é»åã¡ãŒã«ã®äžã§ãããããæç¢ºã«èª¬æããŸãããããŠã€ã«ã¹ã®ç°åžžãªç¹åŸŽã¯ã²ãã ã®æ¬åœã«å°ããªéšå(0.1ïŒ æªæº)ãæ§æããŠããã®ã§ãç¹åŸŽã®ããã€ãã(æœåšçã«)人工çã«èŠããããšãèŠãã«ã¯ããã¹ãŠã®é åãæ¬åœã«ããèŠãªããã°ãªããªãããšã¢ã³ããŒã»ã³ã¯é»åã¡ãŒã«ã«æžããŸããã
"ãèšã£ãŠãããŸããã仿¥è©±ãåã£ãçµæããšãã£ãããããã€ã¯ãç§ã®4人ã¯ããã®ã²ãã ãé²åè«ããäºæ³ãããããšãšççŸããŠãããšèããŠããŸãããããããã£ãšè©³ããèŠãŠãããªããã°ãªããªããããŸã ãŸã åæãå¿ èŠãªã®ã§ãããããæèŠã¯ãŸã å€ããå¯èœæ§ããããŸããããšã圌ã¯ä»ãå ããŸããã"
WIVã§ã®NIHè³éã«ããå±éºãªç ç©¶
ç¿æ¥ã2020幎2æ1æ¥ã®ååŸ2æããã¡ãŠãããã¡ãŒã©ãŒãã³ãªã³ãºãã¢ã³ããŒã»ã³ããŠã€ã«ã¹åŠè æ°åãé»è©±äŒè°ãéããŸããããéºäŒåæäœã®å åã«æ°ã¥ããŠããã®ã¯æããã«ã¢ã³ããŒã»ã³ã ãã§ã¯ãããŸããã§ããã
ãã¡ãŒã©ãŒèªèº«ã¯ããã¹ãã¯ãã©ã ã§ã0ãèªç¶ã§100ãè§£æŸã ãšãããããŒç§ã¯æ£çŽèšã£ãŠ50ã ïŒããšæžããŠããŸãã
The Interceptã«ãããšããã¡ãŠãã¯ãã®æ¥ã®æã"èªåã®æ©é¢ãäžåœã®ç ç©¶æ©é¢ãšã©ã®ãããªå©æéãå ±åç ç©¶ãè¡ã£ãŠããã®ããææ¡ãã"ããšã«è²»ãããŸããã
ãããã圌ã¯ãNIHããšã³ãã«ã¹ã«ç ç©¶å©æéãåºãããšã³ãã«ã¹ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã«ã³ãããŠã€ã«ã¹å®éšã®äžè«ããããŠããããšããã®äžã«ã¯SARSé¢é£ã®ã³ãŠã¢ãªã³ãããŠã€ã«ã¹ã®ãã¡ã©ãã€ããªããã«ææãããããåããŠã¹ã䜿ã£ãå®éšãå«ãŸããŠããããšãç¥ã£ãã®ã§ããã(ãããŸã§ç¥ããªãã£ããšããã°ãããã¯çåã§ãã)ã
The Interceptã«ãããšããŠã€ã«ã¹ãããŸãã«ãç°è³ªã§ããããããããã®å®éšãæ°åã³ãããŠã€ã«ã¹ã«ç¹ãã£ãå¯èœæ§ã¯æ¥µããŠäœããã®ã®ã"æŠæŒ¢ã§ã¯ä»ã«ã©ããªå®éšãè¡ãããŠããã®ããå ¬è¡šãããŠããªãçåãçãã"ãšã®äºã§ãã
NIHãšã€ãªããã®ããç§åŠè ãã¡ã¯ãæåããç ç©¶æããã®æŒæŽ©ãçã£ãŠãã
2020幎2æ2æ¥ããã¡ãŒã©ãŒã¯è°è«ããŸãšããã¡ã¢ãå芧ããŸããã
"å®å
šãªç§å¯"ãšããŠæ±ãããããã«ãšã®äºã§ããã
ãšã³ãããŒããŠã€ã«ã¹ã®äŸµå ¥ããã»ã¹ã®å°éå®¶ã§ãããã€ã±ã«ã»ãã¡ãŒã¶ã³å士ã¯ãæ°åã³ãããŠã€ã«ã¹ãããã®æ°éã®çްèã«ææããèœåãå¯èœã«ããæ°ããç¹åŸŽã§ãããããªã³åæéšäœã®ååšã«æ©ãŸãããã®ã§ãã
ãã¡ãŒã©ãŒã®ã¡ã¢ã«ãããšããã¡ãŒã¶ã³ã¯ãç 究宀ã®å€ã§ã®åºæ¥äºãšããŠèª¬æããã®ã«èŠåŽããŠãããããã§ãã
ãã¡ãŒã©ãŒã®ãŸãšãã«ã¯ãããæžãããŠããŸãïŒ
"âŠæãåŸãããªèª¬æã¯ãBSL-2ã®ç°å¢ã§SARSã®çãããŠã€ã«ã¹(CoV)ãããã®çŽ°èæ ªã䜿ã£ãçµç¹å¹é€ã§é·æéç¶ä»£ãããããªåçŽãªãã®ã§ããå¯èœæ§ãããã®ã§ãããã®çµæãããã®ACE2å容äœã«é©åããããéã§æ¥éã«ææããçŽ å ãšãªãããªã³éšäœãå¶ç¶ã«ç²åŸãããŠã€ã«ã¹ãäœããããšãããã®ã§ãâŠ
"ã§ãããããã®äžé£ã®å¶ç¶ãä¿¡ãããã©ãããæŠæŒ¢ã®ç ç©¶æã«ã€ããŠç¥ã£ãŠããããšãå¶ç¶ã®æŸåºãèªç¶çŸè±¡ãªã©ãã©ãã ãã®ããšãèµ·ããããããããããã©ããŸãšããããåé¡ã«ãªããšæããŸããç§ã¯70:30ã60:40ã ãšæããŸãã"
ææã§åŸ®çç©åŠè ã®ãããŒã(ãã)ã»ã¬ãªã£å士ã®ã¡ã¢ãèŠããšã圌ãåããããªå¿é ãããŠããããšãããããŸãã
"ç§ã¯ãã®nCoVããæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã§é åæ±ºå®ããã96ïŒ ã®ã³ãŠã¢ãªã®CoVãšæŽåããŸãããRBD(å容äœçµåãã¡ã€ã³)ãé€ãã°ãSã¿ã³ãã¯è³ªã¯ã¢ããé žã¬ãã«ã§ã¯æ¬è³ªçã«åäžã§ãããŒãããã12åã®ãã¯ã¬ãªãããå®ç§ã«æ¿å ¥ãããããªã³éšäœã远å ãããŠããŸãã
"S2ã¯ãã®å šé·ã«ããã£ãŠæ¬è³ªçã«åäžã§ããã³ãŠã¢ãªã®ãŠã€ã«ã¹ããããã¯ããã«éåžžã«ãã䌌ããŠã€ã«ã¹ããã4ã€ã®ã¢ããé žãš12åã®ãã¯ã¬ãªãã(åæãã)ãåæã«æ¿å ¥ããŠããã®æ©èœãç²åŸãããããªããã£ãšããããèªç¶ã®ã·ããªãªã¯æãã€ããŸããããŒS2ã®ä»ã®ã¢ããé žã¯å€ããªãã®ã§ããïŒ
"èªç¶çã§ãããã©ã®ããã«éæãããã®ããç§ã«ã¯çè§£ã§ããŸãããã¢ããé žã¬ãã«ã®ã¹ãã€ã¯ã®ã¢ã©ã€ã¡ã³ãããšã£ãŠã¿ããšããã®é©ãã¹ãããšãããããŸãããŒãã¡ãããç 究宀ã§ã¯ãããªããæããããªå®ç§ãª12å¡©åºã®æ¿å ¥ç©ãäœãåºãããšã¯ç°¡åã§ãã
"ããäžã€ã®ã·ããªãªã¯ãnCoVã®åé§äœã¯ãé²åã®éçšã§çããå®ç§ãªããªã³åæéšäœãæã€ã³ãŠã¢ãªã®ãŠã€ã«ã¹ã§ãã£ããšãããã®ã§ãããã®ã·ããªãªã§ã¯ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã®ãŠã€ã«ã¹ã®RaTG13ã¯12ãã¯ã¬ãªããã®å®å šãªæ¬ 倱ã«ãã£ãŠçæãããä»ã®S2ã¢ããé žã¯æ¬è³ªçã«å€åããŠããªã(åæãã)ãšããããšã«ãªããŸããç§èŠã§ãã[ç§ã®æèŠã§ã¯]ããã«ããããªãããšã§ããããã¯å€§ããªifã§ãã"
èšãæããã°ããã³ãããã¯ã®åæã«ãNIHãšé£çµ¡ãåã£ãŠãããŠã€ã«ã¹åŠè
ãã¡ã®éã§ã¯ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æããã®æŒæŽ©èª¬ã¯ãã£ãšãããããšããããšã ãã§ãªããããããæãå¯èœæ§ãé«ããšããã®ãäžè¬çãªã³ã³ã»ã³ãµã¹ã§ããã
ãã®æžç°¡ã¯ããã¡ãŠããšã³ãªã³ãºããã®èª¬ãé»ããããã£ããšããäºå®ã«ã€ããŠãçãã®äœå°ã®ãªããã®ã§ããã
é èœå·¥äœã®éå§
2020幎2æ2æ¥ã®é»åã¡ãŒã«ã§ãã³ãªã³ãºã¯ãèªç¶èµ·æºã®å¯èœæ§ãé«ããšããèŠè§£ã«è¿ã¥ããŠããããšè¿°ã¹ããã®åé¡ãæ±ãå°éå®¶å§å¡äŒãæéããªãéããé°è¬ã®å£°ãããã«æ¯é ããããšèŠåããããããé°è¬ã¯ãç§åŠãšåœé調åã«å€§ããªæå®³ãäžããå¯èœæ§ãããããšææããã®ã§ãã
é»è©±äŒè°ã«åå ãããªã©ã³ãã®ãŠã€ã«ã¹åŠè ãã³ã»ããŒãã§æ°ããç ç©¶æã®æ å ±æŒæŽ©ã«é¢ããè°è«ãç¶ããããšã¯ããäžå¿ èŠã«ãããç ç©¶è ã®çŸåœ¹ã®è·åã劚ããç§åŠå šè¬ãç¹ã«äžåœã®ç§åŠã«äžå¿ èŠãªæå®³ãäžããããšååã«èŠåããŠããŸãã
ãã¡ãŠãã®ã»ãã¯ãåãæ¥(2æ2æ¥)ã«å®éšå®€æµåºèª¬ãæããæ±ºæãããããã§ãã
é»åã¡ãŒã«ã®äžã§ã圌ã¯ããæžããŠããŸãïŒ
"ã©ã®ãããªçµç·¯ã§ãã®ãããªäºæ ã«ãªã£ãã®ãã¯ããããŸããããå€ãã®äººã ãæžå¿µããŠããããšããããŠãœãŒã·ã£ã«ã¡ãã£ã¢äžã§ããã«æªæ²ãããæããããããšãèãããšãè¿ éã«å¯Ÿå¿ããããšãäžå¯æ¬ ã§ãã"
The Interceptã«ãããšããã¡ãŠãããã¡ãŒã©ãŒãã³ãªã³ãºã®3人ã¯äžçä¿å¥æ©é¢(WHO)ã®è·å¡ã«èŠåããå°éå®¶å§å¡äŒãæéããŠèª¿æ»ããŠãããããšãæåŸ ããŸãããã"WHOã¯åœæããããæåŠãã"ããã§ãã
ããããç ç©¶å®€æŒæŽ©èª¬ãåºãŸãã°ããã®å±éºæ§ã¯ååã«æ¿ç¥ããŠããããã以äžã®"åçº"ã黿¢ããããã®èšç»ãç·Žãããããã§ãã
çç©å µåšã®ã¢ã€ãã¢ã黿¢ããããã«æ¥éœäœæãããè«æ
ããã2æ¥åŸã®2020幎2æ4æ¥ããã¡ãŠããšã³ãªã³ãºã¯ãåŸã«Nature Medicineã«æ²èŒãããè«æ"The Proximal Origin of SARS-CoV-2"ã®ç¬¬äžçš¿ãåãåããŸããã
2020幎2æ1æ¥ã®é»è©±äŒè°ã«ã¯ãèè ã®ãã¡ãã¢ã³ããŒã»ã³ããã¥ãŒã¬ã³å€§åŠã®ãããŒãã»ã¬ãªãŒãã·ãããŒå€§åŠã®ãšãã¯ãŒãã»ããŒã ãºã®3人ãåå ããŠããŸããã
ã¢ã³ããŒã»ã³ãã®ã£ãªãŒããããŠããäžäººã®"Proximal Origin"ã®èè ã§ããã³ãã³ãã¢å€§åŠã®Wã»ã€ã¢ã³ã»ãªããã³ãè¿å¹Žãå€é¡ã®NIHè£å©éãåãåã£ãŠããããã®è«æã¯å©å®³é¢ä¿ã®ãªãç¬ç«ããé¢ä¿è ã«ãã£ãŠæžããããã®ã§ã¯ãããŸããã
åæ¡ã¯ãŸã ç§å¯ã§ãã
ãã¡ãŠãããã®ã¡ãŒã«ã®è¿ä¿¡ãããã ãã§ããã®äžã§åœŒã¯ããåããŠã¹ã䜿ã£ãé£ç¶ç¶ä»£ãå«ãŸããŠããããšã«ãã©ã°ãç«ãŠãŠããããã§ãã
ãã®ããšã¯ãåç©å®éšã®åé¡ãæèµ·ããããã®ã®ããã®åŸããã«ç Žæ£ãããããšã瀺åããŠããŸãã
Nature Medicineèªã®èšäºã¯ããã®ãŠã€ã«ã¹ãæå³çã«æäœãããçµæã§ãããšããèããäžè¹Žãããã®ä»£ããã«ã"蚌æ ã¯ä¹ããããèªç¶ã«é²åããå¯èœæ§ãæãé«ã"ãšæå±ããŠããŸãã(èªç¶é²å説ã®å¯èœæ§ã2ã€æããããŠããŸã)
ããããç 究宀ããã®æŒæŽ©ã®å¯èœæ§ãåŠå®ããããã§ã¯ãªãããããŸã§ããæå³çã«ãæäœããããšããèãã§ãã
è«æã®äžã§ã¯ããè¿°ã¹ãããŠããŸãïŒ
"æ°åã³ãããŠã€ã«ã¹ãæå³çã«æäœããããŠã€ã«ã¹ã§ã¯ãªãããšã瀺ã蚌æ ã¯ããããããã«è¿°ã¹ãä»ã®èµ·æºèª¬ã蚌æããããšãå蚌ããããšãä»ã®ãšããäžå¯èœã§ããã
"ããããæé©åãããRBDãå€å¡©åºæ§åæéšäœãå«ãæ°åã³ãããŠã€ã«ã¹ã®æ³šç®ãã¹ãç¹åŸŽã¯ãã¹ãŠèªç¶çã®é¢é£ã³ãããŠã€ã«ã¹ã§èгå¯ãããŠããã®ã§ãå®éšå®€ããŒã¹ã®ã·ããªãªããããªããã®ã§ããããã£ãšãããããšã¯èããŠããªãã"
ç 究宀起æºã¯åŠå®ãããªãã£ã
ãã®è«æã§è¿°ã¹ãããŠãã"èµ·æºã«é¢ããä»ã®èª¬"ã¯ãå®éšå®€ã§æ¥åžžçã«è¡ãããŠãã"ééäžã®éžæ"ã®çµæã§ããå¯èœæ§ãææãããã®ã§ãã
ã€ãŸããçç©å µåšã®ç¯çã«å ¥ããããªã"æå³çã«äœããããšããå"ãææããããšã«æãæ°ã䜿ã£ãããã§ãã
The Interceptãå ±ããããã«ããã¡ãŒã©ãŒããã¡ãŠããã³ãªã³ãºã®3人ã¯ã確ãã«å®éšå®€ç±æ¥ã®å¯èœæ§ãå®å šã«åŠå®ããããã§ã¯ãããŸããã§ããïŒ
"ãã®æç¹ã§ç§åŠè ãã¡ã¯ã[ãŠã€ã«ã¹ãç ç©¶å®€ã§æå³çã«æäœãããã·ããªãª]ãšã[ç 究宀ã§ã®é£ç¶ç¶ä»£å®éšäžã«ãŠã€ã«ã¹ãçæãããã·ããªãª]ãå³»å¥ããŠããããã§ãã
"ããšãã£ã¯ã©ãåŽ(â»ç ç©¶ææŒæŽ©èª¬)ã60ïŒ40ã«ããã§ãããããšãã¡ãŒã©ãŒã¯ä»ãå ããŸããããç§ã¯50:50ã®ãŸãŸã§ãã
"ãããã§ãããåç©ã®å¶çºçå®éšå®€ééã®ææ¡ã«ã¯èå³ããããŸã(ã©ã®åç©ã§ããïŒ)ããšæžããã³ãªã³ãºã
"ããã«ã?? ACE2ãã©ã³ã¹ãžã§ããã¯ããŠã¹ã§ã®é£ç¶æäžããšçãããã¡ãŠãã
"ããã®éãã§ãïŒããšãã¡ãŒã©ãŒãçããŸããã
"ãããã¯BSL-2ã®ç 究宀ã§ã¯ã§ããªãããšã§ãããïŒããšã³ãªã³ãºãæžããŸããã(â»ããã§èšåãããBSL-2ãšã¯)ãã€ãªã»ãŒããã£ã»ã¬ãã«2ã®å®éšå®€ã®ããšã§ãæãå³ããå®å šãããã³ã«ãæããªãå®éšå®€ã§ãã
"ãã¡ãŒã©ãŒã¯ãã¯ã€ã«ãã»ãŠã§ã¹ãâŠããšåå¿ããŸããããããã¯äžåœã®ç ç©¶æã®æ £ç¿ããããã¯æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãã®ãã®ãæããŠãããšæãããŸãã
"äžèšã®ãããšãã®äžã§ä¿å¥åœå±ãšããŠã¯ã[ååã«å®å šã確ä¿ãããŠããªãç ç©¶æã§ãéºäŒåçµã¿æãããŠã¹ãã³ãããŠã€ã«ã¹ãç¹°ãè¿ãééããçµæãæ°åã³ãããŠã€ã«ã¹ãå¶ç¶åºçŸã»æŸåºãããå¯èœæ§]ãèããŠããããã§ãã
"ãã®åŸã®é»åã¡ãŒã«ã®ããåãã§ããã¡ãŒã©ãŒã¯ã®ã£ãªãŒã®èšèãåŒçšããŠãåç©ã§ã®é£ç¶ç¶ä»£ãä»ã®ãŠã€ã«ã¹ãç¹ã«H5N1ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ã«ããªã³åæéšäœãåºçŸãããããšã蚌æãããŠããããšãææããŸãããããã¯ããªã®è«æã«H5N1ã®é£éããã-ããªã³éšäœã段éçã«åºçŸããã"
åæ§ã«ã2æ8æ¥ã®ã¯ãªã¹ãã£ã³ã»ããã¹ãã³å士ãšã¢ã³ããŒã»ã³ã®éã«ããããªãããšãããããŸãã
ããã¹ãã³ã¯ããæžããŠããŸãïŒ
ãã©ãªããã²ãšã€æããŠãã ãããç§ãã¡ã¯ãããçè«ã«ææŠããããã«éãŸããã§ããããšãªããããæšãŠãããšããã®ã§ã¯ãããŸãããïŒæåã«ãã®è©±ãæãã€ããã®ã¯èª°ã§ããïŒèªåãã¡ã®é°è¬è«ãè«ç Žããããã«åããŠããã®ã§ããããïŒã
ã¢ã³ããŒã»ã³ã®åçããã¡ãã§ãïŒ
ãããæ°é±éã®äž»ãªäœæ¥ã¯ãããããã¿ã€ãã®å®éšå®€çè«ãå蚌ããããšããããšã«éäžããŠããŸããããããç§ãã¡ã¯ãæ€èšããã3ã€ã®äž»èŠãªçè«ã®ãããã«å¯ŸããŠãé«ãä¿¡é Œæ§ããããšèšããã»ã©ãç§åŠç蚌æ ãæ±ºå®çã§ãªãå²è·¯ã«ç«ã£ãŠããã®ã§ãã
ãã®ææžãéèªã«æ²èŒããããšã«ã€ããŠã¯ãä»ã®ãšããè³æããŠããŸãããçŸæ®µéã§ã¯ããªãŒãã³ãšã³ããªãã®ãçºè¡šããããšã¯é广ã«ãªããããªããšèããŠããããã§ãã
ã¢ã³ããŒã»ã³ã®æ¶æ¥µçãªæ
床ã«ãããããããè«æã¯1ã«æåŸã®2020幎3æ17æ¥ã«åçãããŸããã
ãŒãããŠããŠã€ã«ã¹ãé£ç¶ééã®çµæã§ããå¯èœæ§ã¯æ®ããããŸãŸã§ããã
å²äžæãèªãŸãããããã¬ã³ãçŽ
"Proximal Origin"è«æã®åœ±é¿åãã©ãã»ã©å€§ããæžããããããã¯å€§è¢è£ã§ã¯ãããŸããã
The Interceptãå ±ããŸããããã«ããã®è«æã¯570äžå以äžã¢ã¯ã»ã¹ããã2,000以äžã®ã¡ãã£ã¢ã§åŒçšããããããŸã§åºçãããäžã§æãèªãŸããè«æã®äžã€ã«ãªã£ãŠããŸãã
ãã®ãããã¬ã³ãã¯ãèªç¶é²åã®ã³ã³ã»ã³ãµã¹ãšããå¹»æ³ãæ¯æããããã«"æãåãæŸãåããã"ãšèšã£ãŠãè¯ãã§ãããã
ã»ãšãã©ã®ã¡ãã£ã¢ã¯ããã®è«æã®çµè«ãèªåŒµããŠå ±éããŠããŸãã
èªç¶é²åèª¬ãæ¯æããå®éã®èšŒæ ãæç€ºãããç 究宀ã§ã®é£ç¶çãªç¶ä»£ã«ãã£ãŠäœãããå¯èœæ§ãèªããªãããABCãã¥ãŒã¹ãªã©ã¯å€§èã«ããé°è¬è«è ã®çãããæ®å¿µã§ãããç ç©¶çµæã¯æ°åã³ãããŠã€ã«ã¹ã¯å®éšå®€ã§äœããããã®ã§ã¯ãããŸããããšããããããã®åé¡ãç§åŠç蚌æ ã«åºã¥ããŠæ±ºå®çã«è§£æ±ºããããã®ããã«çºè¡šããŠããŸãã
çåã¯ææãããªãã£ã
ããã"Nature Medicine"èªã®èšäºã¯ãæµãããçåãæ¢ããããšã¯ã§ããŸããã§ããã
ã³ãªã³ãºã2020幎4æäžæ¬ã«ãã¡ãŠãã«éã£ãé»åã¡ãŒã«ã§ããã®äºå®ãéé£ããŠããŸãïŒ
ããã®éåžžã«ç Žå£çãªé°è¬ã黿¢ããããã«ãNIHã«äœãã§ããããšã¯ãªãããšèããŠããŸãâŠã
æ°åã³ãããŠã€ã«ã¹ã®ã²ãã é åã«é¢ããNature Medicineã®è«æããããã«æ±ºçãã€ããããšãæåŸ ããŸãããããããããããããŸã泚ç®ãããªãã£ãã®ã§ããããç§ãã¡ã«ã§ããããšã¯ãããŸããïŒãã·ã§ãã«ã»ã¢ã«ãããŒã«æèŠãæ±ããŸããïŒã
ãã¡ãŠãã®è¿çã¯ãç§ã¯ä»ããã®ããšã«ã€ããŠäœãããŸãããæä»£ãšãšãã«æ¶ããŠããå ãç©ã®ãããªãã®ã§ã(åæãã)ããšãããã®ã§ããã
åœç¶ã®äºãªããã圌ã¯ééã£ãŠããŸããã
çåãæ¶ããªãã®ã¯ãæ°ããªèšŒæ ãæ¬¡ã
ãšåºãŠããŠç ç©¶ææŒæŽ©èª¬ã匷å(â»ä¿¡ææ§ãå¢ããšããæå³)ãããäžæ¹ã§ãèªç¶é²å説ãè£ä»ãããã®ãäœããªãããã§ãã
ãã³ãã«å€§åŠã®èšç®ãŠã€ã«ã¹åŠè ã§ããã»ã«ã²ã€ã»ãã³ãæ°ã¯ã"The Intercept"ã«ãåœæãçŸåšãã"Proximal Origin"ã§èããããŠãããããªå®éšå®€èµ·æºãå°ãªããšã劥åœã§ãªãããšã決å®çã«ç€ºããããªããŒã¿ã¯ãªãããšèªã£ãŠããŸãã
ã¹ã¿ã³ãã©ãŒã倧åŠã®åŸ®çç©åŠïŒå ç«åŠïŒå»åŠã®ææã§ãããã€ãŽã£ããã»ã¬ã«ãã³æ°ã¯ãç·šéãããŠããªãé»åã¡ãŒã«ãèªãã äžã§ãããä»ãå ããŸããïŒ
"ç§ã2020幎3æã«ãã(Proximal Originè«æ)ãåããŠç®ã«ãããšãããã®è«æã¯è°è«ãæ±ããçµè«ã®ããã«ç§ã«ã¯èªããŸãããæ°ããåé¡ç¹ã®äžã§ããã³ãŠã¢ãªãªã©ã®éå€ãµã³ãã«ããã³ãããŠã€ã«ã¹ã墿®ãããç©æ¥µçãªåãçµã¿ã®äžã§ãç¥ããç¥ããã®ãã¡ã«å¶çºçã«æŒããŠããŸãå¯èœæ§ããŸãšãã«èæ ®ããŠããªãã£ãããšã§ãã
ãŸããæŠæŒ¢ã®ç ç©¶è ãã2019幎ã«åœŒãã®ç 究宀ã«ãã£ããã¹ãŠã®ãŠã€ã«ã¹ãšãã¹ãŠã®é åã«ã€ããŠäžçã«äŒãããšä»®å®ããŠããŸãããããããããã®[ç·šéãããŠããªãé»åã¡ãŒã«]ã¯ãå®éã«ã¯ãèè ãã¡ãè°è«ã®åæã«ãããã€ãã®è¿œå ã®ç 究宀é¢é£ã·ããªãªãæ€èšãããšãã蚌æ ã瀺ããŠããŸãã
ããããã®åŸã圌ãã¯å€æãæ¥ããç 究宀ã·ããªãªã¯æ¯æãããªããªããŸãããããŒã¿ãå°ãªãããšãšã[å®éšå®€èµ·æº]ã·ããªãªã«å¯Ÿããæé»ã®åèŠãéãªã£ãŠã圌ãã®é ã®äžã§ãã®èããèããŠãã£ãããã«èŠããŸãã"
é¡åŸ®é¡ã«æ ããŠã€ã«ã¹åŠè ãã¡
ã¯ã·ã³ãã³ãã¹ãçŽãå ±ããããã«ããŠã€ã«ã¹åŠè
ããã€ãŠãªãã»ã©é¡åŸ®é¡ã®äžã«çœ®ãããNIH㯠"æ¿åºåºè³ã®ç ç©¶ã«é¢ããæ¿çã®ç·ç¹æ€ãæºåããŠãã"ãšèšãããŠããŸãã
1æ20æ¥ã«ããã€ãªã»ãã¥ãªãã£è«®åå§å¡äŒããã®æèšæ¡ãçºè¡šãããŸããã
æããã«ãã©ãã€ã¢ã¯é«ãŸã£ãŠãããããã«ã¯æ£åœãªçç±ããããŸãã
æ°åã³ãããŠã€ã«ã¹ãç ç©¶æã®ãªãŒã¯ã«ãããã®ã§ãããšããéå€§ãªæžå¿µããã£ãããšããããŠãã®æžå¿µã¯"ç§åŠ"ã®ãããã¬ã³ããéãããšã«ãã£ãŠ"åããããã"ããšã瀺ãNIHã®æªä¿®æ£é»åã¡ãŒã«ãããã ãã§ãªããç ç©¶è
ã¯çŸåšæ°åã³ãããŠã€ã«ã¹ã®æ©èœç²åŸç ç©¶ãè¡ã£ãŠããããšã瀺ãç ç©¶çºè¡šãè¡ã£ãŠããã®ã§ãã
"ããæ©èœç²åŸç ç©¶ãæ°åã³ãããŠã€ã«ã¹(â»çºç)ã®äžå ãšãªã£ãã®ã§ããã°ããããäºåºŠãšèµ·ãããªãããã«ããå¿ èŠãããã®ã¯æããã§ãã"
ãŸãšããªç¥çµã®æã¡äž»ãªãããããªããšãèããã¯ãããããŸããã
å±éºãªç
åäœã®ç¡è¬ãªäºéå©çšç ç©¶ãæ¥åžžçã«è¡ãããŠãããšããäºå®ããæ°åã³ãããŠã€ã«ã¹ã®èµ·æºãè§£æããããšãéèŠã§ããæä»¥ã§ãã
ããããã®ãããªç ç©¶ãæ°åã³ãããŠã€ã«ã¹(â»çºç)ã®åå ã«ãªã£ãã®ã§ããã°ãäºåºŠãšèµ·ãããªãããã«ããªããã°ãªããªãã®ã¯æããã§ãã
ç ç©¶æããã®æŒæŽ©èª¬ãããã»ã©ãŸã§ã«è«è°ãããŠããã®ã¯ããããäºå®ãšèªãããšè°äŒãç ç©¶ç£æ¥ãæå¶ããããåŸãªããªãããããšããã®ã第äžã®çç±ã ãšæããŸãã
ãããããããç¡èŠããããšã¯ã§ããŸããã
æ©èœç²åŸåç ç©¶èœåã¯ã人é¡å
šäœã«ãšã£ãŠçã«åç¶ã®å±æ©ãããããããã§ãã
ç£å¯å§å¡äŒã®å ±åæžã¯ãNIHã®äžé£ã®èª€ããéé£ããŠãã
è峿·±ãããšã«ã(â»2023幎)1æ25æ¥ãç±³åœç£å¯ç·ç£å®€ã¯ãNIHãå±éºæ§ã®ããã³ãããŠã€ã«ã¹ç ç©¶ãé©åã«ç£èŠã»å¯©æ»ããŠããªãã£ãããšã詳现ã«ç€ºãå ±åæžãçºè¡šããŸããã
ãããå ±ãããã€ãªãŒã¡ãŒã«çŽã«ãããšïŒ
"ãšã³ãã«ã¹ã¯ã2014幎ãã2021幎ã«ãããŠãæ¿åºã®ç ç©¶å©æé800äžãã«ãç²åŸããç ç©¶æœèšã«äžè«ããšããŠæäŸããŠããŸãããæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã¯ããã®æã«å©æéãç²åŸãã8ããŒã ã®ãã¡ã®1ã€ã§ãã
"æ¬æ¥ã®ç£æ»ã§ã¯ãäžåœã®æœèšãšæ¿åºã®è£å©éã®æ©æµãåããŠããä»ã®ç ç©¶æã«ãããŠãNIHãšãšã³ãã«ã¹ã«ããç£èŠãäžååã§ãã£ããšææããŸããã
"å ±åæžã¯ãããšã³ãã«ã¹ãžã®æŽå©ã®äžã§è¡ãããŠããç ç©¶ã«é¢é£ããæœåšçãªãªã¹ã¯ãç¹å®ããã«ãããããããNIHã¯ãšã³ãã«ã¹ãèŠå®ã®èŠä»¶ãéµå®ããŠãããã©ããã广çã«ç£èŠããã驿ã«å¯ŸåŠããŠããªãããšã倿ããŸãããããšè¿°ã¹ãŠããŸãã
"NIHãšãšã³ãã«ã¹ã¯ç£èŠæé ã確ç«ããŠã¯ããŸããããæã ã¯ãããã®æé ãéµå®ããäžã§ã®æ¬ é¥ãããããããé£éŠå©æéãšãã®äžè«ãå¥çŽã«ãã宿œãããŠããç ç©¶ã®æ§è³ªãçè§£ããæœåšçãªåé¡é åãç¹å®ããæ¯æ£æªçœ®ãåããã«å¹æçã«ç£èŠããNIHãšãšã³ãã«ã¹ã®å¯Ÿå¿èœåã®éçã«å¶çŽãããŠããããšãèŠãã ããŸããâŠ
"調æ»å®ã«ãããšããšã³ãã«ã¹ã¯ãŸããè³éã®äœ¿çšã«é¢ããé©åãªé²æå ±åæžãé©æã«æåºããã2幎é ããŠæ å ±ããããããããšã®ããšã§ãããŸããNIHã¯ãéå¶å©å£äœããããã³ã«ãç Žã£ãåŸããšã³ãã«ã¹ãšã®å©æéãæã¡åããªãã£ããšãèšã£ãŠããŸãã"
çœè¡£æ§å»æ£ç©ãããžã§ã¯ãã®ã¢ããã«ã·ãŒã»å ¬å ±æ¿çæ åœäžçŽå¯ç€Ÿé·ã§ãããžã£ã¹ãã£ã³ã»ã°ãããã³æ°ã¯ããã®å ±åæžã«ã€ããŠæ¬¡ã®ããã«ã³ã¡ã³ãããŠããŸãïŒ
"ãã®ç£æ»ã¯ãç§ãã¡ãæåã«NIHã®æŠæŒ¢ç ç©¶æãžã®è³éæäŸãæŽé²ãã2020幎åé ããèšé²ããŠããããšã確èªãããã®ã§ãããšã³ãã«ã¹ã¯ããããããã³ãããã¯ãåŒãèµ·ãããå±éºãªåç©å®éšã®ããã«æŠæŒ¢ã«çšéãåºè·ããé£éŠæ³ãšæ¿çã«éåããçšéãæµªè²»ããŸããã
"ãããæŠæŒ¢ã®ç ç©¶æã¯ãåç©å®éšã®ããã«ããã«å€ãã®çšéãæå ¥ããè³æ Œãæã¡ç¶ããŠããŸãããã³ãããã¯ãå§ãŸã£ãŠä»¥æ¥ããšã³ãã«ã¹ã¯DOD(ç±³åœé²ç·ç)ãUSAID(ç±³åœééçºåº)ãNIHãNSF(å šç±³ç§åŠè²¡å£)ããå°ãªããšã4600äžãã«ã®æ°ããªé£éŠè³éãããéããŠããã®ã§ãã
"ãšã³ãã«ã¹ã®æŠæŒ¢åç©å®éšå®€ãšã®æ²æšãªå ±åäœæ¥ãæåã«æŽé²ããçµäºãããã°ã«ãŒããšããŠãç§ãã¡ã¯è°äŒã«å¯Ÿãããããã®äžæ£ãªçµç¹ãžã®è³éæŽå©ããã£ã±ããšè¡ãããèŠæ±ããŠããã®ã§ããçŽçšè ã¯ããéãæµªè²»ããæ³åŸãç Žããå ¬è¡è¡çãå±éºã«ãããç¡è¬ãªçœè¡£ã«è³éãæäŸããããšã匷ããããã¹ãã§ã¯ãªãã®ã§ããè³éãæ¢ããçæ°ãæ¢ããŸãããã"
ç±³åœæ¿åºãæ å ±å ¬éè«æ±ãå°é
ææ»åœå±ãçå®ã«è¿«ãããšããäžãç±³åœä¿å¥ç€ŸäŒçŠç¥ç(HHS)ã¯ãããã衚ã«åºãã®ãé²ãããã«ããããæãå°œãããŠããŸãã
U.S. Right to Knowã®å ±åèšç«è ã§ããã²ã€ãªãŒã»ã©ã¹ãã³æ°ãå ±åããããã«ã2022幎ã«HHSãæ°åã³ãããŠã€ã«ã¹ã«é¢ããFOIAèŠè«ãåãããããHHSæ³åéšå ã§4å±€ã®æ³ç審æ»ã远å ããã®ã§ãã
ãããã®åŒè·å£«ã¯ãå
¬éåã«èšŒæ ãšãªããããã®ãé©åã«ç·šéãããŠããããäžã€ã²ãšã€ã®ææžã粟æ»ããŠããŸãã
ãããã¯æããã«ãæ°åã³ãããŠã€ã«ã¹ã®èµ·æºã«é¢ããææžã®å
¬éãé
ããããã黿¢ãããããããã®åªåãšæãããŸãããšã©ã¹ãã³æ°ã¯æžããŸããã
ãHHSã¯äœãé ããŠããã®ã§ããããïŒè°äŒã調æ»ããããšãæã¿ãŸãã
å
±åå
ã®äžé¢ããã®ãããªèª¿æ»ãéå§ããèœåãæã€ããã«ãªã£ãããšã¯è¯ããã¥ãŒã¹ã§ãç§ã¯åœŒããããããããšãæãã§ããŸãã
åé¡ãšããŠã¯ãé èœã蚌æãããšããã¹ãŠãã²ã£ããè¿ãã®ã§å±éºã ãšããããšã§ãã
ä¿å¥æã倧åŠããã®ä»å€ãã®æ©é¢ãåæ§ç¯ãããªããã°ãªããªãã§ãããã
ã ããããã®äºä»¶ã®ççžãç©¶æããã«ã¯ãçå®ãç¥ãããšãèŠçã«å€ãããšä¿¡ãã人ãã¡ãå¿
èŠãªã®ã§ãã
åæã¯Mercolaãå ¬éããŠããŸãã
ãã®èšäºã§ç€ºãããèŠè§£ãæèŠã¯èè ã®ãã®ã§ãããå¿ ãããChildren's Health Defenseã®èŠè§£ãåæ ãããã®ã§ã¯ãããŸããã
çµãã
ãç²ãæ§ã§ãð
ããã¯ãâŠé·ãäžã«ã»ãŒã»ãŒæç« ã°ãããªã®ã§ããèªã¿ã«ãªãããéã®ç²ãæ¹ãçžåœãªãã®ã§ã¯ïŒãšæããŸãððŠ
ããããç®ãçãã§ãww
ãã®èšäºã®ç¿»èš³ãç·šéããŠã¿ãããšæã£ãçç±ãªãã§ããããã¡ãŠãéã«ããé èœå·¥äœãªã©ã®çްããéšåã®ããã®ãã£ãã£ãŒã«ã®çްããããããã®èšäºã¯æ ŒçŽããŠãããæ¹ãåŸã
è¯ãããïŒããšèãããããªãã§ãðŠ
ãã åºæ¬çã«ã¯æžãã人ã®èŠè§£ãªã©ãåæ ãããŠããããããã§ãã®ã§ãããã¯å人ã®èŠè§£ã§ïŒãšããäºã§äžã€ð
ã»æ®æ®µã®æŽ»å
ãããã¯æ®æ®µããã®ãŸãšãèšäºã®ç·šéãæ åœãããæ¹ã ã«æ··ãã£ãп޻åãããŠé ããŠãããŸãð
ãã®ãŸãšãèšäºã¯We The Media(WTM)ãšèšããŸããŠããã¬ã°ã©ã ãšããSNSã«å±éãããŠããåžæ°ãžã£ãŒããªãºã ãªã¡ãã£ã¢ãšãªããŸãðâšâš
ã¡ãã£ã¢ã«å¯çš¿ãããæ¹ãå
è»äººãªæ¹ãªã©ãæ§ã
ãªã¢ã¡ãªã«ã®"æåœè
"éãã²ãšå³éããã¥ãŒã¹ãåãäžãããèŠè§£ãæçš¿ããŠãã£ãŠãããŸãð
ãã®ã¡ãã£ã¢ãèªå翻蚳ããŠããã®ãããµãã€ç®ã®ãªã³ã¯We The Mediaæ¥æ¬èªèš³(WTMjp)ãã£ã³ãã«ãšãªããŸãð
ããããäžã¯ããã®æ®æ®µã®èšäºã§ããã³ãã¬çã«è²Œãä»ããŠãããŸã宣äŒéšåãšãªããŸãð
ç·šéãæ
åœãªãã£ãŠäžããæ¹ãåéäžã§ãã®ã§ãå®ãããã°ãäžå ±ãïŒð
ã»ããåéãªã©
WTMãŸãšãèšäºã®äœæãããŠãè¯ããïŒãšä»°ãæ¹ããéæåéäžã§ããããŸãðâšâš
ãé£çµ¡ã¯WTMjpã®ãŸãšãã¡ã³ããŒã®å
ãããã®ãããç Žå£å€©äœ¿ãããQãªããã©ãã©ãŒãã(ãšãããã)ã®èšäºã®ã³ã¡ã³ãæ¬ããããã¯Twitterãªã©ã®DMã§åãä»ããããŠé ããŸãã
宿çã«âŠã§ãªããŠããäŸãã°ã²ãšæã«1åã2åãšãã§ã倧äžå€«ã§ããïŒ
èšäºãäœããããªãïŒãšå¿é
ãªããã®è²Žæ¹ããèšäºãäœã£ãŠããŸãæ¹ã
ã«ãããµããŒããšãåºæ¥ãŸãã®ã§ãæã£ãŠããããæ·å±
ã¯äœãã®ã§ãð¥Žâšâš
ãããããç¹ã«ããŒã çãªåãçµã¿ãšãã§ã¯ç¡ããšãWTMjpã®æçš¿ã§æ°ã«ãªã£ããæ°ã«å
¥ã£ããã®ãããããŸããããã©ãã©ãèšäºã«ãããSNSãªã©ã§åãäžããŠã¿ãŠäžãããŸãïŒðâšâš
ããããããããè³ãããèŠããïŒãšããã®ããã®çç±ã ã£ããããŸãããäžå³éãæçš¿ã®æ°ã
ã¯å匷ã«ãªããŸãããæ°ãåããŸããããäžèäžãããŸãð¥Žâšâš
ã»åç¥ã£ã£ã£ã£ãïŒïŒïŒ
æ¥æ¬åœå
ãã"äžå³éã£ãã¡ãã£ã¢çãªã³ã³ãã³ã"ãäœã£ãŠã¿ããïŒãšãã¬ã°ã©ã ã«ç£ã¿åºãããã®ã"ããããã¡ãã£ã¢ãã"ïŒ
çŸåšã®ã¡ã³ããŒãšããŸããŠã¯åæã®ã¡ã³ããŒã®
ã®4å+1矜ã«å ããŠâŠ
ãšããé£å®¹ã§ãéããããŠé ããŸãïŒ
ã¡ã³ããŒã«ã€ããŠã¯ãæãèŠãŠå°ããã€å¢å¡ã»åéãªã©ããããšæãããŸãã
ãããåå é ããæ¹ãããã£ããããŸãå Žåã¯ãæ¯éãšã"åœåã®ã¡ã³ããŒ"ã®èšäºã®ã³ã¡ã³ãæ¬ããTwitterã®ã¢ã«ãŠã³ããŸã§ã蚪ãäžãããŸãïŒ
ãŸã ãŸã ç£ãŸãããŠãªãã£ã³ãã«ã§ãããå®ãããé¡ãããŸãð
ããã§ã¯ããŸãããïŒðð
â»ã¿ã°ä»ãçšã«çœ®ããŠãŸãðŠ
#æ¥èš #ã³ã©ã #ãã¥ãŒã¹
#æµ·å€ãã¥ãŒã¹ #ãã¥ãŒã¹ãŸãšã #ç®èŠããæ¥æ¬äºº
#æäºè±èª #ãã¬ãããèŠããªããã¥ãŒã¹
#ã¯ã·ããã¡ãã£ã¢ã #åžæ°ãžã£ãŒããªãºã
#åžžèãçã #åžžèãçã
- #æ¥èš
- #ã³ã©ã
- #ãã¥ãŒã¹
- #æ°åã³ãããŠã€ã«ã¹
- #ã³ãããŠã€ã«ã¹
- #æµ·å€ãã¥ãŒã¹
- #ãã¥ãŒã¹ãŸãšã
- #ç®èŠããæ¥æ¬äºº
- #æäºè±èª
- #åžžèãçã
- #åžžèãçã
- #åžæ°ãžã£ãŒããªãºã
- #ãã¬ãããèŠããªããã¥ãŒã¹
- #ã¯ã·ããã¡ãã£ã¢ã
- #ãã¡ãŠã
- #ãã¡ãŠãå士
- #NIH
- #æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æ
- #ãšã³ãã«ã¹
- #ããŒã¿ãŒã»ãã¶ãã¯å士